Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market
MOUNTAIN VIEW, Calif., Jan. 10, 2011 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter. This new device enables, for the first time, multiple vascular procedures to be performed with one catheter, potentially reducing procedure time and expense for both patients and medical professionals.
The GPSCath™ is a two-in-one device that allows physicians to perform high-pressure angioplasty and inject physician-specified fluids such as contrast while maintaining guidewire position.
"The Hotspur GPSCath™ balloon is a superior alternative to a non-compliant ultra-high-pressure legacy devices currently in use," said Dr. Lin. "This is because the flexible nature of the Hotspur device allows tactile and visual feedback on the stenotic lesion, while still providing the performance of a ultra-high-pressure angioplasty balloon. In addition, the value added feature enables operators to conveniently maintain guidewire position while delivering therapeutic drugs and evaluating results of interventions. This is especially attractive when treating difficult or occlusive lesions. Hotspur is setting a higher bar for peripheral and dialysis access angioplasty performance."
During the first procedure, Dr. Liu successfully restored blood flow through the patient's dialysis access graft by inflating a 7mm GPSCath™ balloon to 20ATM to open a blockage within the graft. After performing the angioplasty, without removing the balloon, Dr. Liu then opened the proprietary valve on the distal end of the GPSCath™ balloon catheter and successfully injected contrast to visualize the angioplasty result. Dr. Liu followed with a second procedure performing both functions utili